Article thumbnail

Protective Effects of Peroxisome Proliferator-Activated Receptor-α Agonist, Wy14643, on Hypoxia/Reoxygenation Injury in Primary Rat Hepatocytes

By Ke Chen, Yuan-Hai Li, Si-Qi Xu, Sheng-Hong Hu and Lei Zhang


This study investigates the effects and possible mechanism of an agonist of PPARα, Wy14643, on primary hepatocytes subjected to H/R injury in rats. H/R induced a significant increase ALT, AST, MDA in the culture medium and ROS in the hepatocytes. These effects were reversed by pretreatment with Wy14643 in the dose-dependent manner. The activity of SOD and the level of GSH in the hepatocytes were decreased after H/R, which were increased by Wy14643 pretreatment. Moreover, the mRNA expressions of PPARα significantly increased in H/R+Wy14643 groups when compared with that in H/R group. A PPARα agonist, Wy14643, exerts significant protective effect against H/R injury in primary hepatocytes via PPARα activation and attenuating oxidative stress

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). Activation of peroxisome proliferator-activated receptor-α protects the heart from ischemia/reperfusion injury,”
  2. (2002). Agonists of peroxisome-proliferator activated receptor-α (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat,”Medical Science Monitor,vol.8,no.12,pp.BR532–BR539,
  3. (2000). Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth,”
  4. (2008). Effects of Wy14643 on hepatic ischemia reperfusion injury in rats,”
  5. (1969). Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues,”
  6. Gerbes et al., “Intravenous administration of glutathione protects parechymal and nonparanchymallivercellsagainstreperfusioninjuryfollowingrat liver transplantation,”
  7. (1997). h a na n dP .J .O ’ B r i e n ,“ R a p i da n ds p e c i fi ce fflux of glutathione before hepatocyte injury induced by hypoxia,”
  8. (2004). Harano et al., “PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats,”
  9. (2004). Heme oxygenase-1 protects human hepatocytes in vitro against warm and cold hypoxia,”
  10. (2001). Hypoxia inhibits the peroxisomeproliferator-activatedreceptorα/retinoidXreceptorgeneregulatorypathwayincardiacmyocytes:amechanism for O2-dependent modulation of mitochondrial fatty acid oxidation,”JournalofBiologicalChemistry,vol.276,no.29,pp. 27605–27612,
  11. (2003). Hypoxia-induced endocytosis, of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta,”
  12. (2001). Hypoxiainvivodecreasesperoxisomeproliferator-activatedreceptor α-regulated gene expression
  13. (2004). Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species,”
  14. (2004). Inflammation, complement, ischemia and amoebic survival in acute experimental amoebic liver abscesses
  15. (2002). Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans,”
  16. (2007). Inhibiting catalase activity sensitizes 36B10 rat glioma cells to
  17. (2008). J.A.Wang,T.L.Chen,J.Jiangetal.,“Hypoxicpreconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells,”
  18. (2005). L l u i s ,A .M o r a l e s ,C .B l a s c oe ta l . ,“ C r i t i c a lr o l eo fm i -tochondrial glutathione in the survival of hepatocytes during hypoxia,”
  19. (1998). Mechanisms of reperfusion injury after warm ischemia of the liver,”
  20. (1978). Microsomal lipid peroxidation,”
  21. (2003). N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients—A pilot study,”
  22. (2006). Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-α agonist
  23. (1999). Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1,”
  24. (1999). Peroxisome proliferator-activated receptor-alpha activators regulate genes governinglipoproteinmetabolism,vascularinflammationand atherosclerosis,”
  25. (2006). Peroxisome proliferator-activated receptors and inflammation,”
  26. (1976). Preparation of isolated rat liver cells,”
  27. (2003). Protectionagainsthepaticischemia-reperfusioninjuryinrats by oral pretreatment with quercetin,”
  28. (2000). Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1α during hypoxia: a mechanismofO
  29. (2003). Redox regulation and signaling lipids in mitochondrial apoptosis,”
  30. (1998). Regulation by hypoxia of methionine adenosyltransferase activityandgeneexpressioninrathepatocytes,”Gastroenterology,
  31. (2010). Seroprevalence of Chlamydophila pneumoniae in ischaemic heart disease,”
  32. (2004). T.OkayaandA.B.Lentsch,“Peroxisomeproliferator-activated receptor-α regulates postischemic liver injury,”
  33. (1993). The nongenotoxic hepatocarcinogen wy-14,643 is an uncoupler of oxidative phosphorylation,”